Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "Innovative Technologies to Treat Diseases of the Back of the Eye"
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Targeting and Design".
Deadline for manuscript submissions: closed (31 May 2022) | Viewed by 31278
Special Issue Editors
Interests: drug delivery; ophthalmic; ocular drug delivery; nanomedicine; microparticles; controlled release
Interests: drug delivery; ophthalmic; ocular drug delivery; nanomaterials; controlled release; biomaterials
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Delivering drugs targeted for posterior segment diseases of the eye in a safe, patient-friendly, and controlled manner has long been the focus of drug delivery researchers. With an aim to develop smart materials capable of the controlled release of ophthalmic drugs relevant in the treatment and management of back of the eye diseases, such research hopes to meet the challenges associated with the global rise in such diseases. Much of the focus has worked towards the development of both nanomaterial delivery carriers and extended-release platforms, such as nano- and micro-devices, implants and contact lenses, as effective means to bypass the ocular barriers and deliver drug efficiently to the posterior segment of the eye. All these innovative technologies are emerging as efficient therapeutic tools in the personalized treatment of back of the eye diseases. The development of animal models of posterior segment diseases is also a critical issue as most of these pathologies are chronic and multifactorial.
Prof. Dr. Rocio Herrero-Vanrell
Dr. Laurence Fitzhenry
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- drug delivery
- ocular controlled release
- posterior segment
- contact lenses